Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) Operating Expenses (2020 - 2025)

Trulieve Cannabis has reported Operating Expenses over the past 6 years, most recently at $159.9 million for Q4 2025.

  • Quarterly results put Operating Expenses at $159.9 million for Q4 2025, down 13.91% from a year ago — trailing twelve months through Dec 2025 was $567.7 million (down 8.14% YoY), and the annual figure for FY2025 was $567.7 million, down 8.14%.
  • Operating Expenses for Q4 2025 was $159.9 million at Trulieve Cannabis, up from $127.6 million in the prior quarter.
  • Over the last five years, Operating Expenses for TCNNF hit a ceiling of $432.9 million in Q2 2023 and a floor of $62.7 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $137.5 million (2022), compared with a mean of $150.0 million.
  • Biggest five-year swings in Operating Expenses: surged 205.1% in 2023 and later plummeted 69.53% in 2024.
  • Trulieve Cannabis' Operating Expenses stood at $144.0 million in 2021, then grew by 5.51% to $151.9 million in 2022, then fell by 17.93% to $124.7 million in 2023, then skyrocketed by 48.96% to $185.7 million in 2024, then fell by 13.91% to $159.9 million in 2025.
  • The last three reported values for Operating Expenses were $159.9 million (Q4 2025), $127.6 million (Q3 2025), and $130.3 million (Q2 2025) per Business Quant data.